The experimental model proposed for this study of the carcinogenesis process are human keratinocytes. These populations can exhibit differentiative function, (keratin) formation and terminal differentiation in vitro on the same substratum as that required to grow the fibroblast upon. We propose to either study the induction stage of carcinogenesis in keratinocytes under conditions where the epithelial morphology of the cells is maintained in vitro and keratin production is repressed, or we can study the carcinogen insult with the cell under conditions where keratin synthesis is operational. We propose to examine the modifying effects compounds such as insulin, PMA or anthralin have on the carcinogenesis process. These compounds when used prior to carcinogen treatment of the fibroblasts have heightened the response to the carcinogen insult. However, keratinocytes have a different program for S phase entry as a function of time following either insulin, PMA or anthralin administration. So it will be of interest to evaluate the carcinogenic response and whether there is a requirement for treatment of keratinocytes with carcinogen in early S or G1/S phase for a heightened response to the insult. Three probes will be used to follow the modifying effect of either PMA, anthralin or insulin on the carcinogenesis process. Calmodulin synthesis and localization in the cell will be followed by indirect immunofluorescent techniques; keratin formation, a marker of cell differentiation, will be followed by indirect immunofluorescent techniques and scheduled DNA synthesis will be followed by 3H-CH3-thymidine incorporation. We will then evaluate the requirement for specific carcinogen-DNA adduct formation and persistence of adducts under conditions where the expression of the carcinogen insult can be modified. Lastly, we will address the assay systems we have developed for measuring a carcinogenic response in vitro. Do human carcinoma cells that exhibit anchorage independent growth, exhibit cellular invasiveness and neoplasia as evaluated in the nude mouse similar to the invitro carcinogen transformations of human keratinocytes?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA025907-06
Application #
3167063
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1979-07-01
Project End
1987-06-30
Budget Start
1986-01-01
Budget End
1987-06-30
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Crowe, D L; Milo, G E; Shuler, C F (1999) Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 78:1256-63
Sun, X L; Li, D; Fang, J et al. (1999) Metastatic conversion of chemically transformed human cells. Gene Expr 8:327-39
Lee, H; Li, D; Prior, T et al. (1997) Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype. Cell Biol Toxicol 13:419-34
Wani, G; Noyes, I; Milo, G E et al. (1997) Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression. Mol Med 3:273-83
Li, D; Yan, H; Chen, J et al. (1996) Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene. Carcinogenesis 17:1751-5
Milo, G E; Li, D; Casto, B C et al. (1996) Malignant conversion of chemically transformed normal human cells. Proc Natl Acad Sci U S A 93:5229-34
Chen, J; Milo, G E; Shuler, C F et al. (1996) Xenograft growth and histodifferentiation of squamous cell carcinomas of the pharynx and larynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:197-202
Li, D; Noyes, I; Shuler, C et al. (1995) Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion. Proc Natl Acad Sci U S A 92:6409-13
Milo, G E; Shuler, C F; Lee, H et al. (1995) A conundrum in molecular toxicology: molecular and biological changes during neoplastic transformation of human cells. Cell Biol Toxicol 11:329-45
Milo, G E; Shuler, C F; Stoner, G et al. (1992) Conversion of premalignant human cells to tumorigenic cells by methylmethane sulfonate and methylnitronitrosoguanidine. Cell Biol Toxicol 8:193-205

Showing the most recent 10 out of 22 publications